Abstract:Background: Non-small cell lung cancer (NSCLC) progression is mediated by changes in gene expression induced by microRNAs. However, the underlying mechanisms remain to be elucidated. In this study, we investigated the roles of miR-183-5p and its target gene in lung cancer development.Methods: Relative levels of miR-183-5p and lysyl oxidase-like 4 (LOXL4) expression in lung cancer cells or tissues were measured by quantitative reverse transcription-polymerase chain reaction (RT-PCR), immunofluorescence or Western blotting as appropriate. The binding of miR-183-5p to LOXL4 sequences was verified by a dual luciferase reporter assay, and cell proliferation was assessed by Cell Counting Kit-8 (CCK-8) and Edu staining. The cell cycle stage and apoptosis were detected by flow cytometry, and Transwell assays were performed to evaluate cell migration and invasion capabilities. The tumorigenic capability of cancer cells was analyzed using a cancer cell line-based xenograft nude mouse model.Results: miR-183-5p expression was decreased in the lung cancer tissues and cell lines and was negatively correlated with elevated LOXL4 expression. Treatment with miR-183-5p mimics suppressed LOXL4 expression, while treatment with an miR-183-5p inhibitor promoted LOXL4 expression in A549 cells. miR-183-5p was found to directly bind to the 3' UTR of the LOXL4 gene in A549 cells. Overexpression of LOXL4 enhanced cell proliferation, cell cycle progression, migration, and invasion, but repressed their apoptosis, and activated extracellular matrix (ECM) and the epithelial mesenchymal transition (EMT) process in A549 cells, while LOXL4 knockdown produced the opposite effects. Treatment with an miR-183-5P inhibitor promoted the proliferation, cell cycle progression, migration, and invasion of A549 cells but suppressed their apoptosis, and activated the ECM and EMT process, while all these effects were abrogated by LOXL4 knockdown. The tumorigenic capability of A540 cells in nude mice was greatly impaired by treatment with miR-183-5p mimics.Conclusions: miR-183-5p repressed the proliferation, migration, invasion, ECM formation, and EMT processes, and promoted the apoptosis of lung cancer cells by targeting LOXL4 expression.

Knockdown of Li-cadherin Increases Metastatic Behaviors of LoVo Cells

Knockdown of LI-cadherin Alters Expression of Matrix Metalloproteinase-2 and -9 and Galectin-3

The effect of down－regulating LOX on invasion and migration in nsopharyngeal carcino-ma cells

[Effects of Lysyl Oxidase Down-Regulation on Invasion, Migration and E-cadherin Protein Expression of Hypoxic Lung Cancer Cells].

Effect of cancer-testis antigen LDHC on the invasion and metastasis of renal cell carcinoma

Influence of LOX Downregulation by RNAi on Hypoxic Metastasis of Human Lung Cancer Cell and the Underlying Molecular Mechanism

Dlk1 Promotes Lung Cancer Cell Invasion Through Upregulation Of Mmp9 Expression Depending On Notch Signaling

Downregulation of LINC00115 inhibits the proliferation and invasion of lung cancer cells in vitro and in vitro

Knockdown of Linc00511 Inhibits TGF-β-induced Cell Migration and Invasion by Suppressing Epithelial-Mesenchymal Transition and Down-Regulating MMPs Expression.

LRRC45 promotes lung cancer proliferation and progression by enhancing c-MYC, slug, MMP2, and MMP9 expression

Research Progress of Relationship Between Abnormal Expression of LI-Cadherin and Tumor Invasion and Metastasis

MiR-629-5p Promotes the Invasion of Lung Adenocarcinoma Via Increasing Both Tumor Cell Invasion and Endothelial Cell Permeability

Altered Expression of a Li-Cadherin in Gastric Cancer and Intestinal Metaplasia

Novel long non-codingRNA LINC02323promotes epithelial-mesenchymal transition and metastasis via spongingmiR-1343-3p in lung adenocarcinoma

Mir-483-5p Promotes Invasion and Metastasis of Lung Adenocarcinoma by Targeting Rhogdi1 and Alcam

LIM-domain Binding Protein 2 Was Down-Regulated by Mirna-96-5p Inhibited the Proliferation, Invasion and Metastasis of Lung Cancer H1299 Cells

LINC02418 promotes malignant behaviors in lung adenocarcinoma cells by sponging miR-4677-3p to upregulate KNL1 expression

LINC01419 Promotes Cell Proliferation and Metastasis in Lung Adenocarcinoma Via Sponging Mir-519B-3p to Up-Regulate RCCD1

miR-183-5p regulates ECM and EMT to promote non-small cell lung cancer progression by targeting LOXL4

Regulation of colon cancer cell migration and invasion by CLIC1-mediated RVD

Long Noncoding RNA LINC00673-v4 Promotes Aggressiveness of Lung Adenocarcinoma Via Activating WNT/β-catenin Signaling.